Purchase Order 19PCRD25KH090
- Not listed
- The U.S. Department of State's Bureau of Administration awarded a $12,173.36 firm fixed-price purchase order to Biofire Defense LLC on July 7, 2025, for the procurement of medical supplies with an ultimate completion date of August 2, 2025. The contract, which carries no set-aside designation, represents a delivery order under the Department of State's $4.5 million Blanket Purchase Agreement with Biofire Defense for laboratory testing supplies. Biofire Defense, a Salt Lake City-based...
- This is a $12,395.20 firm fixed-price purchase order awarded by the U.S. Department of State's Bureau of Administration to Biofire Defense LLC, a for-profit limited liability company based in Salt Lake City, Utah. The contract is for the provision of medical supplies, with no set-aside designation. Biofire Defense is a manufacturer of biological agent identification products and advanced diagnostic solutions, including the Biofire FilmArray and RAZOR Mk II systems, which are designed for rapid...
- Biofire Defense LLC, a Salt Lake City-based manufacturer of molecular diagnostic technologies, was awarded a $4,439.70 firm fixed-price call order under a Blanket Purchase Agreement with the U.S. Department of State's Bureau of Administration for Biofire Lab Test Kits and Products. This contract is designated as a Total Small Business set-aside and represents a delivery order against the existing $4.5 million BPA that covers specialized laboratory testing supplies, including FilmArray...
- Biofire Defense LLC, a Salt Lake City-based manufacturer of molecular diagnostic technologies, was awarded an $8,306.53 firm fixed-price call order under a Blanket Purchase Agreement with the Department of State's Bureau of Administration for biofire lab test kits and products. This award, issued on May 14, 2025, with an ultimate completion date of June 25, 2025, is designated as a Total Small Business set-aside. The call order represents a drawdown against the larger $4.5 million BPA that the...
- Biofire Defense LLC, a Salt Lake City-based manufacturer of molecular diagnostic technologies, was awarded a call order valued at $7,733.66 under a Blanket Purchase Agreement (BPA) with the Department of State's Bureau of Administration for biological laboratory test kits and products. This award, issued on July 22, 2025, with a completion date of September 1, 2025, is designated as a Total Small Business set-aside contract under a firm fixed-price arrangement. The call order represents a draw...
- Biofire Defense LLC, a Salt Lake City-based manufacturer of molecular diagnostic technologies, was awarded a $16,262.03 firm fixed-price Blanket Purchase Agreement (BPA) call order by the Department of State's Bureau of Administration on December 19, 2025. This Total Small Business set-aside contract, with an ultimate completion date of January 27, 2026, covers Biofire lab test kits and products. The award leverages Biofire Defense's existing $4.5 million BPA with the Department of State for...
- The Department of State's Bureau of Administration awarded a BPA (Blanket Purchase Agreement) call order to Biofire Defense LLC on September 15, 2025, for biofire lab test kits and products. This contract, valued at $7,733.66 with a firm fixed-price structure, is designated as a Total Small Business set-aside and is scheduled for completion by October 27, 2025. The order represents a call against Biofire Defense's existing $4.5 million BPA with the State Department for laboratory testing...
- Biofire Defense LLC, a Salt Lake City-based manufacturer of molecular diagnostic technologies, has been awarded a $6,928.72 firm fixed-price call order under a Blanket Purchase Agreement with the Department of State's Bureau of Administration for BioFire lab test kits and products. This Total Small Business set-aside award, issued on December 22, 2025, with completion targeted for January 30, 2026, represents a call against the larger $4.5 million BPA that covers specialized laboratory testing...
- <p>The Department of State Bureau of Administration awarded a $89,657 delivery order to Biofire Defense LLC of Salt Lake City, Utah for the purchase of Biofire Defense consumables. The firm fixed price order was awarded on September 22, 2020, with an anticipated completion date of October 16, 2020. No set-aside designation was applied to this procurement. Biofire Defense LLC will provide consumables in support of the Department of State's biodefense programs.</p>
- The Department of State Bureau of Administration awarded a $68,208 firm fixed price delivery order to Biofire Defense LLC of Salt Lake City, Utah. The order is for consumables to support the BIOFIRE DEFENSE system under the potential value of the task order through its completion date of March 31, 2023. Biofire Defense LLC will provide consumable supplies needed to operate the BIOFIRE DEFENSE diagnostic platform for the Department of State. No set-aside designation was used for this award made...
The U.S. Department of State's Bureau of Administration awarded a $12,173.36 firm fixed-price purchase order to Biofire Defense LLC on July 22, 2025, for medical supplies with an ultimate completion date of August 8, 2025. This contract, with no set-aside designation, is issued against the Department of State's existing $4.5 million Blanket Purchase Agreement with Biofire Defense for laboratory testing supplies. The work will be performed in Salt Lake City, Utah, where Biofire Defense is headquartered. Biofire Defense specializes in manufacturing molecular diagnostic technologies, including its FilmArray and RAZOR Mk II systems, which support biodefense and public health preparedness objectives across federal agencies. This purchase order represents a routine draw-down from the larger Department of State BPA, which covers specialized laboratory testing supplies including FilmArray Respiratory Panels 2.1, Gastrointestinal Panel Tests, and Global Fever Special Pathogens Tests. Biofire Defense has established itself as a critical vendor for federal agencies requiring rapid and accurate diagnostic testing technologies, with prior awards from the Department of Defense, National Institutes of Health, Defense Health Agency, and other defense and civilian agencies. The company's comprehensive diagnostic capabilities and proven performance under existing indefinite delivery vehicles position it as a strategic provider for federal infectious disease and biological threat detection requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.2k | 7/22/25 |